Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C von Fakih, Marwan G, Salvatore, Lisa, Esaki, Taito, Modest, Dominik P, Lopez-Bravo, David P, Taieb, Julien, Karamouzis, Michalis V, Ruiz-Garcia, Erika, Kim, Tae-Won, Kuboki, Yasutoshi, Meriggi, Fausto, Cunningham, David, Yeh, Kun-Huei, Chan, Emily, Chao, Joseph, Saportas, Yaneth, Tran, Qui, Cremolini, Chiara, Pietrantonio, Filippo

Volltext

A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C - mutated colorectal cancer von Yaeger, Rona, Langer, Corey J., Ruffinelli, Jose Carlos, Fakih, Marwan, Furqan, Muhammad, Machiels, Jean-Pascal H., Saportas, Yaneth, Nolte-Hippenmeyer, Jane, Chan, Emily, Xia, Caihong, Masuishi, Toshiki

Volltext

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria von Kulasekararaj, Austin, Lanza, Francesco, Arvanitakis, Alexandros, Langemeijer, Saskia M.C., Chonat, Satheesh, Chow, Vincent, Pan, Jean, Saportas, Yaneth, Hanes, Vladimir, Henary, Haby

Volltext